Professional Documents
Culture Documents
P.G. Paul, MBBS, DGO, Gaurav Chopade, MBBS, MS, DNB, Saurabh Patil, MBBS, MS,
Tanuka Das, MBBS, MS, DNB, Manju Thomas, MBBS, MS, and Reena Garg, MBBS, DGO
Abstract
Objective: The aim of this research was to evaluate the feasibility and surgical outcomes of laparoscopic surgery for
large ovarian cysts in women <40 years of age. Materials and Methods: This was a retrospective evaluation
(Canadian Task Force classification 11-2 design) of 55 women (ages <40) with large ovarian cysts (‡10 cm) with
features suggestive of benign disease managed laparoscopically at Paul’s Hospital, in Cochin, Kerala, from July
2006 to April 2013. All patients were followed-up for a minimum of 1 year. Patients who were diagnosed as having
borderline ovarian tumors were evaluated for their present clinical status at the end of study. Results: Laparoscopic
surgery was performed successfully for all patients. The mean operative time, estimated blood loss, and hospital
stay were, respectively, 109.6 minutes (range: 40–255), 304.6 mL (range: 100–650), and 1.1 days (range: 1–3).
Conversion to laparotomy was performed in none of the patients. Five cases of borderline malignancy were
detected. Of these 5 cases; 3 underwent laparoscopic adnexectomy; 1 underwent bilateral cystectomy with staging
biopsies, conceived 3 months postsurgery, and subsequently underwent laparoscopic adnexectomy at another
center; and 1 underwent a unilateral laparoscopic cystectomy, and had a laparotomy and adnexectomy in another
institution after 1 month. Conclusions: The current study supports laparoscopic management of large ovarian cysts
as a technically feasible and effective method if proper case selection is applied. ( J GYNECOL SURG 32:251)
Centre for Advanced Endoscopy and Infertility Treatment, Paul’s Hospital, Cochin, Kerala, India.
251
252 PAUL ET AL.
Table 2. Operative Details plaints were abdominal pain in 65.45%, and dysmenorrhea in
14.54%, and 12.72% of the patients presented with infertility,
Variables N = 55 while 7.27% had irregular cycles. Twelve patients had his-
tories of previous surgeries. Fifty-two percent of the patients
Duration of surgery (min)
Mean (range) 109.6 (40–255) had CA-125 values >35 international units(IU)/mL, with a
Fluid aspirated (mL) mean value of 95 IU/mL, which was not statistically signif-
Mean (range) 1700.91 (500–6000) icant. Risk of Malignancy Index (RMI) scores of all the pa-
EBL (mL) tients were <200. The mean (range) ADNEX [Assessment of
Mean (range) 304.64 (100–650) Different NEoplasias in the adneXa] model score of all the
Type of laparoscopic surgery patients was 97.39% (95%–98.2%) benign.5
Unilateral cystectomy 23 (41.81%) The mean duration of surgery and EBL were 109.6 min-
Bilateral cystectomy 14 (25.45%) utes (range: 40–255) and 304.6 mL (range 100–650), re-
Unilateral cystectomy + 7 (12.73%) spectively (Table 2). The mean duration of hospital stay was
staging biopsy 1.1 day (range: 1–3). Two patients had postoperative fever,
Bilateral cystectomy + 2 (3.63%)
staging biopsy and 1 patient had a primary-trocar site infection. There were
Unilateral adnexectomy 5 (9.09%) no conversions to laparotomy and no major intraoperative
Unilateral adnexectomy + 3 (5.45%) complications. Laparoscopic surgical procedures performed
staging biopsy were as follows: unilateral cystectomy in 23 patients; bilat-
Right adnexectomy + 1 (1.82%) eral cystectomy in 14 patients; staging biopsy in 12 patients,
left cystectomy unilateral adnexectomy in 5 patients; and right adnexectomy
Hospital stay (days) with left cystectomy in 1 patient. Histopathologic exami-
Mean (range) 1.1 (1–3) nations of the cysts showed that 40.0% of the patients had
Histopathology endometriosis, 14.54% had serous cyst adenomas, 18.18%
Endometriosis 22 (40.00%) had dermoid cysts, 14.54% had mucinous cyst adenomas,
Serous cyst adenoma 8 (14.54%)
Mucinous cyst adenoma 8 (14.54%) and 9.09% had borderline tumors.
Mixed epithelial 2 (3.63%) Clinicopathologic factors are shown in Table 3. The
Dermoid cyst 10 (18.18%) proportion of patients with borderline malignancy was sig-
Borderline tumor 5 (9.09%) nificantly higher among those with cysts ‡20 cm but this
was not statistically significant.
min, minutes; EBL, estimated blood loss. There were 5 cases of borderline malignancy (Table 4). In
1 case, preoperatively, a 24-year-old female had normal
Statistical analyses tumor markers and no signs that were suggestive of malig-
All statistical analyses were performed with the IBM nancy on ultrasonography and MRI, but she underwent a
SPSS for Windows, version 20.0. An analysis of variance test bilateral cystectomy with staging biopsies, which, on his-
was used to compare the quantitative characteristics of the topathology testing, revealed a borderline mucinous tumor.
patients and the outcomes. A chi-square test or Fisher’s exact This patient conceived spontaneously 3 months after sur-
test was used to calculate the associations among qualitative gery, delivered normally, and subsequently had an open
characteristics, with significance set at p < 0.05. hysterectomy with a bilateral salpingo-ophorectomy in an-
other center for recurrence of the cyst.
Three other patients with borderline malignancy had
Results
normal tumor markers and no signs suggestive of malig-
Patients’ characteristics are shown in Table 1. The mean nancy noted on ultrasonography and MRI. These patients
age of patients was 26.96 years (range: 15–8). The mean BMI underwent laparoscopic adnexectomies, which, on histo-
was 25.05 (range: 18–42 kg/m2). Forty percent were celibate pathologic examination, revealed borderline mucinous tu-
and 27.27% were nulligravida. The mean diameter of the mors with foci of microinvasion. These patients did not
ovarian cysts was 13.9 cm (range: 10.0–24.0). Chief com- undergo any other surgeries or receive any chemotherapy
yrs, years, IU, international units; RMI, Risk of Malignancy Index; ADNEX, Assessment of Different NEoplasias in the adneXa; FTND, full-term normal delivery; mo, month; P, para; L, live.
salpingo-ophorectomy for recurrence
after this surgery. There were no recurrences noted on
follow-ups at 1, 6 and 12 months.
There was another 25-year-old patient who had unilateral
Follow-up (May 2014)
after 8 yrs)
in another institution 1 month after the first surgery.
Clinicopathologic factors of patients with borderline ma-
lignancy are compared in Table 5. Borderline malignancy
was significantly associated with multilocularity on ultra-
sonography.
All of the patients were followed up for a period of 1 year
mucinous tumor
mucinous tumor
mucinous tumor
mucinous tumor
mucinous tumor
Histopathology
microinvasion
at 1, 6 and 12 months with clinical examinations, CA-125,
with foci of
transabdominal sonography, and transvaginal sonography.
Borderline
Borderline
Borderline
Borderline
Borderline
Table 4. Characteristics of Patients’ Borderline Ovarian Tumors
Discussion
biopsies (23/2/2010)
with staging biopsy
Type of laparoscopic
Unilateral cystectomy
Right adnexectomy
Right adnexectomy
(7/11/2006)
(28/2/2006)
(5/8/2011)
90/98.1
39/96.4
100/96.3
ADNEX
115/95
Multiloculated cyst
Multiloculated cyst
Multiloculated cyst
multiloculated
cyst without
the current study, the mean age of the patients was 26.96
Bilateral
23
10
20
19
11
30
115
39
100
sterilized
Celibate
24
25
28
38
5
LAPAROSCOPY FOR LARGE OVARIAN CYSTS 255
shown that, with copious saline irrigation, postoperative undergo a repeat laparoscopic cystectomy 3 years after her
chemical peritonitis is <1%.15,16 primary surgery.
The reverse Trendelenburg position is important at the Port-site metastasis after laparoscopic removal of malig-
end of the procedure to optimize the results of lavaging. In nant tissue is another reported complication.20,21 In the cur-
cases of dermoid cysts, the cystectomies were performed in rent cases, the ovarian cysts were extracted using an endobag
endobags to reduce spillage, whereas, in a study by Chong to prevent port-site contamination. None of these patients
et al., a puncture site on a cyst was held using a Kelly clamp developed metastatic lesions on trocar sites during the study’s
to prevent spillage.11 Irrigating the abdominal cavity with follow-up period.
several L of saline involves long operating time, which is a Because of the potential risk of malignancy, selection of
limitation of the current authors’ technique. Conversion to patients for laparoscopic management of large ovarian cysts
laparotomy occurred in none of the patients, whereas con- is very important. It is generally agreed that ovarian cancer
version to laparotomy occurred in 4.9%–6.1% of patients in should not be managed laparoscopically, especially when
other studies.2,12 operators are not able to perform the surgical procedure
In the current study, histopathologic examination revealed without rupture.22 It is uncertain whether or not an intra-
benign tumors in 90.91% of the cases, and 5 cases (9.09%) operative rupture has the same prognostic significance as
had borderline malignancy, which was high compared to the ovarian-surface involvement and/or positive peritoneal wash-
3.7% reported by Lim et al.12 However, in the Lim et al. ings in stage I ovarian cancers.23–26 However, most patients
study, the incidence of invasive epithelial ovarian carcinoma with ruptured cysts need postoperative chemotherapy. The
was 2.5%, and, in the current study, there were no cases of new ADNEX Model scoring system can help to some ex-
malignancy.12 All of the 5 cases of borderline malignancy tent in early detection of borderline malignancy. When an
had no features (exclusion criteria) suggestive of malignancy adenexectomy is planned, use of an endobag helps pre-
noted on preoperative workups, and their RMI scores were vent spillage of contents. In cases of small cysts, enucleation
<200.17 All borderline malignancy cases were multiloculated, in toto helps prevent spillage. For large cysts, aspiration in the
compared to 14% in the benign group, which was statistically reverse Trendelenburg position minimizes spillage risk.
significant. Two of the borderline malignancies were >20 cm, Lecuru et al., in a retrospective multicenter study, sug-
but this was not statistically significant, compared to the sizes gested that there was no difference in outcome after lapa-
of the benign cysts. roscopic management of ovarian cancer, but surgical staging
According to Fauvet et al., borderline malignancy can be was suboptimal in a significant number of laparoscopically
managed by laparoscopic cystectomy or adnexectomy and managed cases.27 In the current study, laparoscopic staging
patient survival is not affected, although the chance of re- biopsies of ovarian cysts was performed in 12 cases (22.2%)
currence was high in that study’s cystectomy group.18 How- that had intraoperative findings that were suspicious of
ever, tumor recurrence and metastatic disease are rare in malignancy. Exploration of the retroperitoneum for lymph
borderline mucinous ovarian tumors.19 In the current study, nodes was not performed, as MRI/CT scans did not reveal
there were 5 cases of borderline malignancy and 1 of these any enlarged lymph nodes. However, in cases of malig-
patients underwent unilateral laparoscopic cystectomy and nancy, this staging is suboptimal and was a limitation of the
another 1 underwent bilateral cystectomy with staging bi- current study. Nonavailability of frozen section was also a
opsies. The former patient underwent laparotomy and ad- limitation of the current study.
nexectomy at another center 1 month later, while the latter In the current study, a higher incidence of borderline ma-
patient conceived 3 months postsurgery, and post delivery lignancy was observed than had been seen in other studies.
she had an open hysterectomy with a bilateral salpingo- The current authors agree that there could have been a se-
ophorectomy for recurrence of her cyst. The other 3 patients lection bias in the cohort, as the Paul Hospital center is
underwent unilateral adnexectomies with staging biopsies known for laparoscopic management in infertility and gy-
performed in one of these procedures. These 3 patients were necology rather than gynecology/oncology. Thus, patient
normal at follow-up. selection was not optimal. When selecting patients for
There was a recurrence of an endometriotic cyst in only 1 management of ovarian cysts laparoscopically, the potential
patient, who presented with primary infertility; she had to risk of malignancy is a major concern. Large cysts with
256 PAUL ET AL.
multilocularity noted on ultrasonography scans should alert 13. Stamatellos I, Karydas C, Anagnostou E, Stamatopoulos P,
clinicians to doubt the benign nature of such cysts. The role Apostolidis A, Bontis I. Laparoscopic treatment of pre-
of sonography has been emphasized in the recent ADNEX menopausal patients with benign adnexal pathology. Gy-
Model scoring system. However, laparoscopic management necol Surg 2006;3:66.
of large ovarian cysts is technically feasible if proper patient 14. Göçmen A, Atak T, Uçar M, Sanlikal F. Laparoscopy-
selection is made. assisted cystectomy for large adnexal cysts. Arch Gynecol
Obstet 2009;279:17.
Conclusions 15. Zanetta G, Ferrari L, Mignini-Renzini M, Vignali M,
Fadini R. Laparoscopic excision of ovarian cysts with
The limiting factor for laparoscopic management of large controlled intraoperative spillage: Safety and effectiveness.
ovarian cysts is not cyst size but rather the potential risk J Reprod Med 1999;44:815.
of malignancy, given that a higher incidence of borderline 16. Nezhat CR, Kalyoncu S, Nezhat CH, Johnson E, Berlanda
malignancy was observed. Large multiloculated ovarian cysts N, Nezhat F. Laparoscopic management of ovarian der-
should be considered as potentially malignant and an oncol- moid cysts: Ten years’ experience. JSLS 1999;3:179.
ogist should be consulted for an opinion. Adnexectomy may 17. National Institute for Health and Care Excellence (NICE).
be a better option for such cases, provided that the contralat- Ovarian Cancer: Recognition and Initial Management:
eral ovaries are normal. The current study supports laparo- NICE Guidelines [CG122]. April 2011. Online document
scopic management of large ovarian cysts as a technically at: www.nice.org.uk/guidance/cg122 Accessed June 8, 2016.
feasible and effective method if proper case selection is made. 18. Fauvet R, Boccara J, Dufournet C, Ponecelet C, Daraı̈ E.
Laparoscopic management of borderline ovarian tumors:
Author Disclosure Statement Results of a French multicenter study. Ann Oncol 2005;
16:403.
The authors declare that they have no conflicts of interest.
19. Chen VW, Ruiz B, Killeen JL, et al. North American As-
References sociation of Central Cancer Registries Supplement to
Cancer: Pathology and classification of ovarian tumors.
1. Alobaid A, Memon A, Alobaid S, Aldakhil L. Laparoscopic Cancer 2003;97(suppl120):2631.
management of huge ovarian cysts. Obstet Gynecol Int 2013; 20. Magrina JF. Laparoscopic surgery for gynecologic cancers.
2013:380854. Clin Obstet Gynecol 2000;43:619.
2. Eltabbakh GH, Charboneau AM, Eltabbakh NG. Laparo- 21. Kruitwagen RF, Swinkels BM, Keyser KG, Doesburg WH,
scopic surgery for large benign ovarian cysts. Gynecol Schijf CP. Incidence and effect on survival of abdominal
Oncol 2008;108:72. wall metastases at trocar or puncture sites following lapa-
3. Marana R, Ferrari S, Scarpa A, Muzii L. Laparoscopic roscopy or paracentesis in women with ovarian cancer.
treatment of adnexal cystic masses [in Italian]. Minerva Gynecol Oncol 1996;60:233.
Ginecol 2006;58:371. 22. Dembo AJ, Davy M, Stenwig AE, Berle EJ, Bush RS,
4. Palmer R. Safety in laparoscopy. J Reprod Med 1974;13:1. Kjorstad K. Prognostic factors in patients with stage I ep-
5. Van Calster B, Van Hoorde K, Valentin L, et al.; Interna- ithelial ovarian cancer. Obstet Gynecol 1990;75:263.
tional Tumor Analysis Group. Evaluating the risk of 23. Leitao MM Jr, Boyd J, Hummer A, et al. Clinicopathologic
ovarian cancer before surgery using the ADNEX model to analysis of early-stage sporadic ovarian carcinoma. Am J
differentiate between [sic] benign, borderline, early and ad- Surg Pathol 2004;28:147.
vanced stage invasive, and secondary metastatic tumours: Pro- 24. Vergote I, De Brabanter J, Fyles A, et al. Prognostic im-
spective multicentre diagnostic study. BMJ 2014;349:g5920. portance of degree of differentiation and cyst rupture in
6. Ou CS, Liu YH, Zabriskie V, Rowbotham R. Alternate stage I invasive epithelial ovarian carcinoma. Lancet 2001;
methods for laparoscopic management of adnexal masses 357:176.
greater than 10 cm in diameter. J Laparoendosc Adv Surg 25. Sevelda P, Dittrich C, Salzer H. Prognostic value of the
Tech A 2001;11:125. rupture of the capsule in stage I epithelial ovarian carci-
7. Yuen PM, Yu KM, Yip SK, Lau WC, Rogers MS, Chang noma. Gynecol Oncol 1989;35:321.
A. A randomized prospective study of laparoscopy and 26. Canis M, Rabischong B, Houlle C, et al. Laparoscopic
laparotomy in the management of benign ovarian masses. management of adnexal masses: A gold standard? Curr
Am J Obstet Gynecol 1997;177:109. Opin Obstet Gynecol 2002;14:423.
8. Shindolimath VV, Jyoti SG, Patil KV, Ammanagi AS. 27. Lecuru F, Desfeux P, Camatte S, Bissery A, Robin F, Blanc
Laparoscopic management of large ovarian cysts at a rural B, Querleu D. Stage I ovarian cancer: Comparison of lap-
hospital. J Gynecol Endosc Surg 2009;1:94. aroscopy and laparotomy on staging and survival. Eur J
9. Salem HA. Laparoscopic excision of large ovarian cysts. Gynaecol Oncol 2004;25:571.
J Obstet Gynaecol Res 2002;28:290.
10. Goh SM, Yam J, Loh SF, Wong A. Minimal access ap-
proach to the management of large ovarian cysts. Surg Address correspondence to:
Endosc 2007;21:80. P.G Paul, MBBS, DGO
11. Chong GO, Hong DG, Lee YS. Single-port (OctoPort) as- Centre for Advanced Endoscopy
sisted extracorporeal ovarian cystectomy for the treatment and Infertility Treatment
of large ovarian cysts: Compare [sic] to conventional lap- Paul’s Hospital
aroscopy and laparotomy. J Minim Invasive Gynecol 2015; Vattekkattu Road
22:45. Kaloor, Cochin 682 017, Kerala
12. Lim S, Lee KB, Chon SJ, Park CY. Is tumor size the India
limiting factor in a [sic] laparoscopic management for large
ovarian cysts? Arch Gynecol Obstet 2012;286:1227. E-mail: drpaulpg@gmail.com
Copyright of Journal of Gynecologic Surgery is the property of Mary Ann Liebert, Inc. and its
content may not be copied or emailed to multiple sites or posted to a listserv without the
copyright holder's express written permission. However, users may print, download, or email
articles for individual use.